Yaara Dromi has over 10 years of experience in quality assurance and management roles in the pharmaceutical industry. She has led quality assurance teams and ensured compliance with regulations from agencies like the FDA and EMA. Her experience includes managing clinical supplies quality assurance at Teva Pharmaceuticals and serving as GMP Group Leader and Associate at Biotechnology General.
The 7 Deadly Sins of Quality Assurance and Quality Control - Pharma IQ eBookPharma IQ
The Seven Sins of QA and QC are those transgressions which are detrimental to quality and profitability. You will probably commit some of them every day. We asked the global pharmaceutical community what they thought were the biggest sins that people commit in quality assurance and quality control and the same ones kept coming up over and over again.
quality assurance, quality control, total quality management UNIT 1, b pharma 6th sem
Quality management in the drug industry
Why quality is important in pharmaceuticals?
Impacts of ignorance on quality
Quality control
Role of quality control in pharmaceutical industry
Objectives of quality control
Components of quality control
Functions of qc in pharmaceutical industry
Quality assurance
Total quality management
Characteristics of tqm
Benefits of tqm:
NATIONAL ACCREDITATION BOARD FOR TESTING AND CALIBRATION LABORATORI0ES (NABL)SAM VIVEK
NABL specifies the general requirements for the competence to carry out tests and calibrations, including sampling. It covers testing and calibration performed using standard methods, non-standard methods, and laboratory-developed methods.
Benefits of Accreditation:
Potential increase in business due to enhanced customer confidence and satisfaction.
Savings in terms of time and money due to reduction or elimination of the need for re-testing .
Better control of laboratory operations and feedback to laboratories as to whether they have sound Quality Assurance System and are technically competent.
The 7 Deadly Sins of Quality Assurance and Quality Control - Pharma IQ eBookPharma IQ
The Seven Sins of QA and QC are those transgressions which are detrimental to quality and profitability. You will probably commit some of them every day. We asked the global pharmaceutical community what they thought were the biggest sins that people commit in quality assurance and quality control and the same ones kept coming up over and over again.
quality assurance, quality control, total quality management UNIT 1, b pharma 6th sem
Quality management in the drug industry
Why quality is important in pharmaceuticals?
Impacts of ignorance on quality
Quality control
Role of quality control in pharmaceutical industry
Objectives of quality control
Components of quality control
Functions of qc in pharmaceutical industry
Quality assurance
Total quality management
Characteristics of tqm
Benefits of tqm:
NATIONAL ACCREDITATION BOARD FOR TESTING AND CALIBRATION LABORATORI0ES (NABL)SAM VIVEK
NABL specifies the general requirements for the competence to carry out tests and calibrations, including sampling. It covers testing and calibration performed using standard methods, non-standard methods, and laboratory-developed methods.
Benefits of Accreditation:
Potential increase in business due to enhanced customer confidence and satisfaction.
Savings in terms of time and money due to reduction or elimination of the need for re-testing .
Better control of laboratory operations and feedback to laboratories as to whether they have sound Quality Assurance System and are technically competent.
quality assurance slides include components, models, approaches, cycle of quality assurance is included in the slides.
the slide gives a brief ides regarding all the points and gives a comprehensive picture of the topic.
A detailed study on the guidelines that are taken for ICH which is also known as the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. The chapter deals with an overview of Quality, Safety, Efficacy and Multidisciplinary guidelines and then a detailed study on the Quality Guidelines. Also a detailed learning of Stability Testing Guidelines proposed by the International Conference for Harmonization.
Role of hospital management related to patient safety in hospitals and the active roles played by them to improve patient safety. Details of actionable on part of hospital management pertaining to safety in hospitals.
ICH: Introduction, objectives & guidelines: A brief insight.RxVichuZ
This is my 44th powerpoint........deals with ICH guidelines.....
Deals with brief introduction, precise objectives, organization(in short) & guidelines (in precise), based on SAFETY, EFFICACY, QUALITY & MULTIDISCIPLINARY guidelines.
Happy reading!!
:)
quality assurance slides include components, models, approaches, cycle of quality assurance is included in the slides.
the slide gives a brief ides regarding all the points and gives a comprehensive picture of the topic.
A detailed study on the guidelines that are taken for ICH which is also known as the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. The chapter deals with an overview of Quality, Safety, Efficacy and Multidisciplinary guidelines and then a detailed study on the Quality Guidelines. Also a detailed learning of Stability Testing Guidelines proposed by the International Conference for Harmonization.
Role of hospital management related to patient safety in hospitals and the active roles played by them to improve patient safety. Details of actionable on part of hospital management pertaining to safety in hospitals.
ICH: Introduction, objectives & guidelines: A brief insight.RxVichuZ
This is my 44th powerpoint........deals with ICH guidelines.....
Deals with brief introduction, precise objectives, organization(in short) & guidelines (in precise), based on SAFETY, EFFICACY, QUALITY & MULTIDISCIPLINARY guidelines.
Happy reading!!
:)
Role of quality systems and audits in pharmaceutical manufacturing environmentMalay Pandya
By regulation, appropriate practice, and common sense, quality assurance (QA) is a critical function in the pharmaceutical manufacturing environment. The need for an independent unit to audit and comment on the appropriate application of standard operating procedures, master batch records, procedures approved in product applications, and the proper functioning of the quality control (QC) unit is paramount.
This helps assure that products are manufactured reliably, with adherence to approved specifications, and that current good manufacturing practices (cGMP) are maintained in conformance to regulation, both in the facility in general and the microenvironment of each product ’s manufacturing sequence.
Ian brings 16 years of experience in the Biotech/Pharmaceutical Industry in Quality Assurance and Quality Control. He has extensive knowledge of all of the applicable regulatory requirements.
My last projects as an independent contractor were with SHIRE, LONZA and NOVARTIS. I conducted Product Investigations from Inoculations of Media to Manufacturing projects which included from line clearance issues to inclusions of foreign material. Also, Inspection of all product packaging to determine a non-negative product impact.
1. Yaara Dromi
7 Elaine Court, Bentleigh East, VIC 3165 ♦ Tel: 03 9017 0152; Cell: 04 2461 5655 ♦ email: yaara_dromi@yahoo.com
QUALITY ASSURANCE ♦ MANAGER/SUPERVISOR & AUDITOR
More than 10+ years experience in driving quality management strategies, compliance and leading change initiatives
within a production environment. Strong compliance focus, with the knowledge needed to integrate Quality Management
Systems, and drive audits for FDA, EMA, ISO and other health authority requirements. Expert in GMP (Good Manufacturing
Process), and effective knowledge of GCP, Annex 13, Annex 16, FDA 21 CFR and other relevant regulatory matters. Strong
risk-manage approach and skilled negotiator. Able to lead multiple levels of staff.
• QA/QC Frameworks • Continuous Improvement • GMP Management
• Clinical Studies • ISO & FDA Compliance • Internal Audit Management
• Supplier Audits & Compliance • OHS Certification • Quality Management Systems
• Clean rooms behaviour • SOPs Implementation • Supply Chain Improvement
• Vendor Management
• International relations with
suppliers and colleagues
• Staff Management • Writing Procedures
SELECTED HIGHLIGHTS
2013 to 2014 Head of Quality Assurance for Clinical Supplies | Teva Pharmaceuticals
2011 to 2012 GMP Group Leader | Biotechnology General
2008 to 2011 GMP Associate | Biotechnology General
2006 to 2007 Technical Support | Orgenics
2001 to 2004 Laboratory Technician | Sheba Medical Center
2000 to 2001 Laboratory Technician | Weizmann Institute of Science
PROFESSIONAL EXPERIENCE
Teva Pharmaceuticals Jan 2013 to Jun 2014
Teva Pharmaceutical Industries Ltd. is an international pharmaceutical company specialising in generic and proprietary pharmaceuticals
and active pharmaceutical ingredients, and employing over 46,000 staff.
HEAD OF QUALITY ASSURANCE for Clinical Supplies
• Drove the quality management strategy and plan, and led the daily efforts including managements and
resorts planning to deliver finished clinical products to clinical studies.
• Established and maintained key quality indicator elements, organised quality goals and objectives. Identified,
assessed and incorporated best demonstrated industry practices to assure GMP and regulatory compliance
with all local and international applicable regulatory requirements and applicable guidance documents.
• Reviewed and approved documentation relating to clinical supplies including the review and approval of
supplier plan documents, and study supplier performance documents and final release for clinical studies.
• Built relationships between the QA division and supply chain management.
• Oversaw quality aspects of clinical supplies including packaging, shipping and handling of drug products.
• Part of the optimisation and harmonization team of the Global SOPs for the clinical supply chain processes,
Private & Confidential Yaara Dromi Page 1of 3
2. and actively served as subject matter experts on QA strategies.
• Managed relationships with third party vendor for packaging, and successfully trained and gave
accountability to the vendor to undertake pre-inspections, resulting in reduced time to pre-release stage.
• Championed continuous improvements efforts, including analysis and review of quality attributes and
determination of Quality Improvement Parameters.
• Developed and conducted training for QA Associates, supply chain and other associated personnel.
• Compiled technical agreements formulation and negotiation with vendors and internal entities.
• Recognised need for investigation due to deviation from written procedures, conduct investigation into non-
conformance incidents/deviations and lead the closure of historical deviations that have historically
remained on this system following disagreements between different entities.
• Led Change control and Risk assessment management.
• Conducted performance annual and random audits, taking necessary action to eliminate risk as necessary.
• Grew the team to four staff from two, being qualified, high personal level, intelligent personnel (Master in
science or higher), with responsibility for training, performance and management.
Biotechnology General Apr 2011 to Dec 2012
Bio-Technology General (Israel) Ltd. is an integrated biopharmaceutical company, BTG has a diverse portfolio of therapeutic products
targeted at niche markets selling to over 40 markets.
GMP GROUP LEADER
• Developed interpreted and implemented quality policies, quality new systems, and facilitated regulatory
compliance to support manufacturing and QC testing of all commercial products and phase 2-3 production.
• Reviewed GMP quality metrics. Analysed data relating to process validations, process controls, and
continuous process improvement efforts. Presented KPI’s and reports to senior management.
• Oversaw the manufacturing of API to drug product and medical devices.
• Provided guidance, interpretation, support, training, and input on the interpretation of regulations,
guidelines, company procedures, and policies. Trained sterile filling personnel on how to dress, behave and
act in the sterile filling in order to eliminate environmental and product contamination.
• Shortened the batch records review by defining the critical parameters to check.
• Assisted in local and international regulatory inspections including FDA,
• Reduced environmental testing according to regulatory requirements and scientific reasoning.
• Oversaw the internal audit program with a focus on cGMP compliance and implementation of CAPA.
Recommended systems for audit, coordinated schedules and followed up corrective actions.
• Managed a team of 8 staff (at academic level) with multiple responsibilities including: Batch record review,
Aseptic processing oversight, manufacturing and QC deviations, investigation management and
multidisciplinary investigations and projects.
Biotechnology General Jan 2008 to Apr 2011
GMP ASSOCIATE
• Provided oversight on manufacturing and QC testing under the GMP requirements, and aligning quality
management strategy to support the release of final product.
• Supported a key project to mitigate risk relating to product disposition, identifying issues within the sterile
filing suite, resulting in environmental contaminations.
Private & Confidential Yaara Dromi Page 2of 3
3. • Managed all deviations and CAPAs handling.
• Controlled batch record reviews, and oversaw asptic processing.
Previous Positions Held:
• Technical Support
Orgenics, 2006 to 2007
• Laboratory Technician
Sheba Medical Center, 2001 to 2004
• Laboratory Technician
Weizmann Institute of Science, 2000 to 2001
ADDITIONAL SUPPORTING INFORMATION
Qualifications & Accreditations:
• Master of Science (MSc), Human/Medical Genetics
Tel Aviv University,2004
• Bachelor of Science (BSc), Animal Sciences
The Hebrew University, 2001
• High School Diploma, Mathematics and Physics
Haderah High School,1993
Publications:
• Tabori et al. Epidermal Growth Factor Receptor Gene Amplification and Expression in Disseminated Pediatric Low
Grade Gliomas. Journal of Neurosurgery (Pediatric 4) 103:357-361, 2005
Courses & Professional Studies
• Managerial Course
• CRA Qualification Course, PharmaJob
• ISO 9001(V 2008), ADL College
• Clean Room Design, Maintenance & Cleaning, Cleanroom Compliance, Inc
• Analysis and Characterization of Protein Therapeutic Drugs, BioForum
• RCA, Root Cause Analysis, Bioforum
• Fermentation Technology Principles and Practice, MLBC
• Capa and Product Lifecycle Approach, Bioforum
• Cleaning in Place (CIP) Technology Principles and Practice, MLBC
Full referee details can be supplied upon request
Private & Confidential Yaara Dromi Page 3of 3